A Neurotoxic Glycerophosphocholine Impacts PtdIns-4, 5-Bisphosphate and TORC2 Signaling by Altering Ceramide Biosynthesis in Yeast


Unbiased lipidomic approaches have identified impairments in glycerophosphocholine second messenger metabolism in patients with Alzheimer's disease. Specifically, we have shown that amyloid-β42 signals the intraneuronal accumulation of PC(O-16:0/2:0) which is associated with neurotoxicity. Similar to neuronal cells, intracellular accumulation of PC(O-16:0/2:0) is also toxic to Saccharomyces cerevisiae, making yeast an excellent model to decipher the pathological effects of this lipid. We previously reported that phospholipase D, a phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2)-binding protein, was relocalized in response to PC(O-16:0/2:0), suggesting that this neurotoxic lipid may remodel lipid signaling networks. Here we show that PC(O-16:0/2:0) regulates the distribution of the PtdIns(4)P 5-kinase Mss4 and its product PtdIns(4,5)P2 leading to the formation of invaginations at the plasma membrane (PM). We further demonstrate that the effects of PC(O-16:0/2:0) on the distribution of PM PtdIns(4,5)P2 pools are in part mediated by changes in the biosynthesis of long chain bases (LCBs) and ceramides. A combination of genetic, biochemical and cell imaging approaches revealed that PC(O-16:0/2:0) is also a potent inhibitor of signaling through the Target of rampamycin complex 2 (TORC2). Together, these data provide mechanistic insight into how specific disruptions in phosphocholine second messenger metabolism associated with Alzheimer's disease may trigger larger network-wide disruptions in ceramide and phosphoinositide second messenger biosynthesis and signaling which have been previously implicated in disease progression.


Vyšlo v časopise: A Neurotoxic Glycerophosphocholine Impacts PtdIns-4, 5-Bisphosphate and TORC2 Signaling by Altering Ceramide Biosynthesis in Yeast. PLoS Genet 10(1): e32767. doi:10.1371/journal.pgen.1004010
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1004010

Souhrn

Unbiased lipidomic approaches have identified impairments in glycerophosphocholine second messenger metabolism in patients with Alzheimer's disease. Specifically, we have shown that amyloid-β42 signals the intraneuronal accumulation of PC(O-16:0/2:0) which is associated with neurotoxicity. Similar to neuronal cells, intracellular accumulation of PC(O-16:0/2:0) is also toxic to Saccharomyces cerevisiae, making yeast an excellent model to decipher the pathological effects of this lipid. We previously reported that phospholipase D, a phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2)-binding protein, was relocalized in response to PC(O-16:0/2:0), suggesting that this neurotoxic lipid may remodel lipid signaling networks. Here we show that PC(O-16:0/2:0) regulates the distribution of the PtdIns(4)P 5-kinase Mss4 and its product PtdIns(4,5)P2 leading to the formation of invaginations at the plasma membrane (PM). We further demonstrate that the effects of PC(O-16:0/2:0) on the distribution of PM PtdIns(4,5)P2 pools are in part mediated by changes in the biosynthesis of long chain bases (LCBs) and ceramides. A combination of genetic, biochemical and cell imaging approaches revealed that PC(O-16:0/2:0) is also a potent inhibitor of signaling through the Target of rampamycin complex 2 (TORC2). Together, these data provide mechanistic insight into how specific disruptions in phosphocholine second messenger metabolism associated with Alzheimer's disease may trigger larger network-wide disruptions in ceramide and phosphoinositide second messenger biosynthesis and signaling which have been previously implicated in disease progression.


Zdroje

1. WymannMP, SchneiterR (2008) Lipid signalling in disease. Nat Rev Mol Cell Biol 9: 162–176.

2. Di PaoloG, KimTW (2011) Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat Rev Neurosci 12: 284–296.

3. WoodPL (2012) Lipidomics of Alzheimer's disease: current status. Alzheimers Res Ther 4: 5.

4. ChanRB, OliveiraTG, CortesEP, HonigLS, DuffKE, et al. (2012) Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J Biol Chem 287: 2678–2688.

5. RyanSD, HarrisCS, MoF, LeeH, HouST, et al. (2007) Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid. J Neurochem 103: 88–97.

6. RyanSD, WhiteheadSN, SwayneLA, MoffatTC, HouW, et al. (2009) Amyloid-beta42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolism. Proc Natl Acad Sci U S A 106: 20936–20941.

7. RyanSD, HarrisCS, CarswellCL, BaenzigerJE, BennettSA (2008) Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons. J Lipid Res 49: 2250–2258.

8. SantosAX, RiezmanH (2012) Yeast as a model system for studying lipid homeostasis and function. FEBS Lett 586: 2858–2867.

9. KennedyMA, KabbaniN, LambertJP, SwayneLA, AhmedF, et al. (2011) Srf1 is a novel regulator of phospholipase D activity and is essential to buffer the toxic effects of C16:0 platelet activating factor. PLoS Genet 7: e1001299.

10. RudgeSA, MorrisAJ, EngebrechtJ (1998) Relocalization of phospholipase D activity mediates membrane formation during meiosis. J Cell Biol 140: 81–90.

11. SciorraVA, RudgeSA, PrestwichGD, FrohmanMA, EngebrechtJ, et al. (1999) Identification of a phosphoinositide binding motif that mediates activation of mammalian and yeast phospholipase D isoenzymes. EMBO J 18: 5911–5921.

12. SciorraVA, RudgeSA, WangJ, McLaughlinS, EngebrechtJ, et al. (2002) Dual role for phosphoinositides in regulation of yeast and mammalian phospholipase D enzymes. J Cell Biol 159: 1039–1049.

13. LandmanN, JeongSY, ShinSY, VoronovSV, SerbanG, et al. (2006) Presenilin mutations linked to familial Alzheimer's disease cause an imbalance in phosphatidylinositol 4,5-bisphosphate metabolism. Proc Natl Acad Sci U S A 103: 19524–19529.

14. BermanDE, Dall'ArmiC, VoronovSV, McIntireLB, ZhangH, et al. (2008) Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism. Nat Neurosci 11: 547–554.

15. McIntireLB, BermanDE, MyaengJ, StaniszewskiA, ArancioO, et al. (2012) Reduction of synaptojanin 1 ameliorates synaptic and behavioral impairments in a mouse model of Alzheimer's disease. J Neurosci 32: 15271–15276.

16. FilippovV, SongMA, ZhangK, VintersHV, TungS, et al. (2012) Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases. J Alzheimers Dis 29: 537–547.

17. HanX, RozenS, BoyleSH, HellegersC, ChengH, et al. (2011) Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One 6: e21643.

18. HanX, DMH, McKeelDWJr, KelleyJ, MorrisJC (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 82: 809–818.

19. CutlerRG, KellyJ, StorieK, PedersenWA, TammaraA, et al. (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A 101: 2070–2075.

20. StefanCJ, AudhyaA, EmrSD (2002) The yeast synaptojanin-like proteins control the cellular distribution of phosphatidylinositol (4,5)-bisphosphate. Mol Biol Cell 13: 542–557.

21. FadriM, DaquinagA, WangS, XueT, KunzJ (2005) The pleckstrin homology domain proteins Slm1 and Slm2 are required for actin cytoskeleton organization in yeast and bind phosphatidylinositol-4,5-bisphosphate and TORC2. Mol Biol Cell 16: 1883–1900.

22. AudhyaA, LoewithR, ParsonsAB, GaoL, TabuchiM, et al. (2004) Genome-wide lethality screen identifies new PI4,5P2 effectors that regulate the actin cytoskeleton. EMBO J 23: 3747–3757.

23. BurdCG, EmrSD (1998) Phosphatidylinositol(3)-phosphate signaling mediated by specific binding to RING FYVE domains. Mol Cell 2: 157–162.

24. StrahlT, ThornerJ (2007) Synthesis and function of membrane phosphoinositides in budding yeast, Saccharomyces cerevisiae. Biochim Biophys Acta 1771: 353–404.

25. AudhyaA, FotiM, EmrSD (2000) Distinct roles for the yeast phosphatidylinositol 4-kinases, Stt4p and Pik1p, in secretion, cell growth, and organelle membrane dynamics. Mol Biol Cell 11: 2673–2689.

26. StolzLE, HuynhCV, ThornerJ, YorkJD (1998) Identification and characterization of an essential family of inositol polyphosphate 5-phosphatases (INP51, INP52 and INP53 gene products) in the yeast Saccharomyces cerevisiae. Genetics 148: 1715–1729.

27. Singer-KrugerB, NemotoY, DaniellL, Ferro-NovickS, De CamilliP (1998) Synaptojanin family members are implicated in endocytic membrane traffic in yeast. J Cell Sci 111(Pt 22): 3347–3356.

28. StefanCJ, PadillaSM, AudhyaA, EmrSD (2005) The phosphoinositide phosphatase Sjl2 is recruited to cortical actin patches in the control of vesicle formation and fission during endocytosis. Mol Cell Biol 25: 2910–2923.

29. SunY, CarrollS, KaksonenM, ToshimaJY, DrubinDG (2007) PtdIns(4,5)P2 turnover is required for multiple stages during clathrin- and actin-dependent endocytic internalization. J Cell Biol 177: 355–367.

30. LingY, StefanCJ, MacgurnJA, AudhyaA, EmrSD (2012) The dual PH domain protein Opy1 functions as a sensor and modulator of PtdIns(4,5)P(2) synthesis. EMBO J 31(13): 2882–94.

31. NewpherTM, SmithRP, LemmonV, LemmonSK (2005) In vivo dynamics of clathrin and its adaptor-dependent recruitment to the actin-based endocytic machinery in yeast. Dev Cell 9: 87–98.

32. GallegoO, BettsMJ, Gvozdenovic-JeremicJ, MaedaK, MatetzkiC, et al. (2010) A systematic screen for protein-lipid interactions in Saccharomyces cerevisiae. Mol Syst Biol 6: 430.

33. KobayashiT, TakematsuH, YamajiT, HiramotoS, KozutsumiY (2005) Disturbance of sphingolipid biosynthesis abrogates the signaling of Mss4, phosphatidylinositol-4-phosphate 5-kinase, in yeast. J Biol Chem 280: 18087–18094.

34. TabuchiM, AudhyaA, ParsonsAB, BooneC, EmrSD (2006) The phosphatidylinositol 4,5-biphosphate and TORC2 binding proteins Slm1 and Slm2 function in sphingolipid regulation. Mol Cell Biol 26: 5861–5875.

35. MiyakeY, KozutsumiY, NakamuraS, FujitaT, KawasakiT (1995) Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun 211: 396–403.

36. BerchtoldD, WaltherTC (2009) TORC2 plasma membrane localization is essential for cell viability and restricted to a distinct domain. Mol Biol Cell 20: 1565–1575.

37. BerchtoldD, PiccolisM, ChiaruttiniN, RiezmanI, RiezmanH, et al. (2012) Plasma membrane stress induces relocalization of Slm proteins and activation of TORC2 to promote sphingolipid synthesis. Nat Cell Biol 14: 542–547.

38. AronovaS, WedamanK, AronovPA, FontesK, RamosK, et al. (2008) Regulation of ceramide biosynthesis by TOR complex 2. Cell Metab 7: 148–158.

39. SchmidtA, KunzJ, HallMN (1996) TOR2 is required for organization of the actin cytoskeleton in yeast. Proc Natl Acad Sci U S A 93: 13780–13785.

40. KamadaY, FujiokaY, SuzukiNN, InagakiF, WullschlegerS, et al. (2005) Tor2 directly phosphorylates the AGC kinase Ypk2 to regulate actin polarization. Mol Cell Biol 25: 7239–7248.

41. LoewithR, HallMN (2011) Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics 189: 1177–1201.

42. HelliwellSB, HowaldI, BarbetN, HallMN (1998) TOR2 is part of two related signaling pathways coordinating cell growth in Saccharomyces cerevisiae. Genetics 148: 99–112.

43. FangY, ParkIH, WuAL, DuG, HuangP, et al. (2003) PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1. Curr Biol 13: 2037–2044.

44. FangY, Vilella-BachM, BachmannR, FlaniganA, ChenJ (2001) Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294: 1942–1945.

45. YoonMS, SunY, ArauzE, JiangY, ChenJ (2011) Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect. J Biol Chem 286: 29568–29574.

46. ToschiA, LeeE, XuL, GarciaA, GadirN, et al. (2009) Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Mol Cell Biol 29: 1411–1420.

47. ZhangC, WendelAA, KeoghMR, HarrisTE, ChenJ, et al. (2012) Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling. Proc Natl Acad Sci U S A 109: 1667–1672.

48. NilesBJ, MogriH, HillA, VlahakisA, PowersT (2012) Plasma membrane recruitment and activation of the AGC kinase Ypk1 is mediated by target of rapamycin complex 2 (TORC2) and its effector proteins Slm1 and Slm2. Proc Natl Acad Sci U S A 109: 1536–1541.

49. WaltherTC, BricknerJH, AguilarPS, BernalesS, PantojaC, et al. (2006) Eisosomes mark static sites of endocytosis. Nature 439: 998–1003.

50. Sanchez-MejiaRO, NewmanJW, TohS, YuGQ, ZhouY, et al. (2008) Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci 11: 1311–1318.

51. SweetRA, PanchalingamK, PettegrewJW, McClureRJ, HamiltonRL, et al. (2002) Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiol Aging 23: 547–553.

52. KleinJ (2000) Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm 107: 1027–1063.

53. FunatoK, RiezmanH (2001) Vesicular and nonvesicular transport of ceramide from ER to the Golgi apparatus in yeast. J Cell Biol 155: 949–959.

54. LongtineMS, McKenzieA3rd, DemariniDJ, ShahNG, WachA, et al. (1998) Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14: 953–961.

55. GriffithJ, MariM, De MaziereA, ReggioriF (2008) A cryosectioning procedure for the ultrastructural analysis and the immunogold labelling of yeast Saccharomyces cerevisiae. Traffic 9: 1060–1072.

56. LuJ, HeltonTD, BlanpiedTA, RaczB, NewpherTM, et al. (2007) Postsynaptic positioning of endocytic zones and AMPA receptor cycling by physical coupling of dynamin-3 to Homer. Neuron 55: 874–889.

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2014 Číslo 1
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa